Research Shows! Codes increase the risk of blood clots by 8 times compared to vaccines.

 Codes increase the risk of blood clots by 8 times compared to vaccines, research shows.

The risk of blood clots in patients and coronavirus disease cod 19 is eight times higher than the risk of a blood clot with the use of a vaccine, according to media reports. The study included 500,000 cod patients and the researchers found that coronavirus patients were 100 times more likely to have blood clotage in cod-protected patients.

The study found that 39 out of every 1 million cod patients are diagnosed with a dangerous type of blood clot, 5 out of every 1 million people who take the estrogen vaccine, and 4 out of every 1 million people who use the Pfizer or modern vaccine. This is the first major research to show the extent to which codes can pose a life-threatening hazard. The study found that such an effect exists in all age groups around the world. Similarly, and one-third of those with COD 19 had blood clots under 30 years of age.

Professor Paul Harrison, head of the actual team, said the results provided important information about the data, which was not yet widely known. He said there were currently concerns about a possible link between vaccines and blood clots. Is being expressed and the use of specific vaccines in different countries is being restricted or suspended, but the answer to an important question is not known what is the risk of blood clots in patients with code 19. He said that we have 2 facts. The first fact was that cod 19 increased the risk of blood clots and it should be included in the list of problems with this epidemic, while the second fact was that cod 19 vaccines Compared to Code 19, the risk is much higher.

He said this is a fact that must be taken into account in order to strike a balance between the benefits and in the risks of vaccination. The study looked at cases of blood clots diagnosed with code 19 or 2 weeks after the first dose of a vaccine. 

These results were compared with the incidence of blood clots in flu patients and the rate of blood clotting cases in the general population was also taken into account. The study found that the risk of blood clots in cod patients is a health hazard. It is 100 times more common in men and 30 percent of patients under the age of 30 who codify it. Researchers emphasize that although the study was conducted under the auspices of the University of Oxford, which developed the astrazenica vaccine. But the research was independent.